Company:  SCICLONE PHARMACEUTICALS ... (SCLN)
Form Type:  4
Filing Date:  2/17/2017 
CIK:  0000880771 
Address:  950 TOWER LANE
SUITE 900
 
City, State, Zip:  FOSTER CITY, California 94404-2125 
Telephone:  650-358-3456 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$11.00  
Change: 
0.10 (0.92%)  
Trade Time: 
Jul 21  
Market Cap: 
$569.69M
Trade SCLN now with 

© 2017  
Description of Business
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) is a United States ("U.S.")-headquartered, China-focused, specialty pharmaceutical company with a substantial commercial business and a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders. We are focused on continuing to grow our revenue and profitability. Our business and corporate strategy is focused primarily on the People's Republic of China ("China" or "PRC") where we have built a solid reputation and established a strong brand through many years of experience marketing our lead product, ZADAXIN (thymalfasin). In addition, we have an established business model with large pharmaceutical partners to promote and sell products. We believe our sales and marketing strengths position us to benefit from the long-term expansion of the pharmaceutical market in China.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES